Informa plc (LON:INF) Given Consensus Rating of “Moderate Buy” by Brokerages

Informa plc (LON:INF) has received an average rating of “Moderate Buy” from the six research firms that are covering the company, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is GBX 1,100.83.

Separately, Citigroup dropped their target price on shares of Informa from GBX 1,000 to GBX 850 and set a “neutral” rating on the stock in a report on Thursday, April 9th.

Insider Buying and Selling

In other Informa news, insider Stephen A. Carter acquired 222 shares of the stock in a transaction dated Wednesday, May 20th. The shares were bought at an average cost of GBX 809 per share, for a total transaction of £1,795.98. Also, insider Gareth Wright acquired 222 shares of the stock in a transaction dated Wednesday, May 20th. The stock was acquired at an average price of GBX 809 per share, for a total transaction of £1,795.98. 0.23% of the stock is owned by company insiders.

Informa Stock Down 0.6%

Shares of LON INF opened at GBX 802.40 on Thursday. The firm has a market capitalization of £10.10 billion, a PE ratio of 1,003.00, a price-to-earnings-growth ratio of 0.75 and a beta of 0.71. The company has a current ratio of 0.44, a quick ratio of 1.70 and a debt-to-equity ratio of 61.56. Informa has a 1 year low of GBX 719 and a 1 year high of GBX 1,000. The firm’s 50-day moving average is GBX 802.70 and its 200-day moving average is GBX 838.75.

Informa (LON:INF) last released its quarterly earnings data on Thursday, March 12th. The company reported GBX 56 earnings per share for the quarter. Informa had a net margin of 1.64% and a return on equity of 0.87%. Equities analysts expect that Informa will post 59.3240265 EPS for the current year.

About Informa

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.